Trastuzumab Emtansine

An antibody-drug conjugate (ADC) consisting of the recombinant anti-epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab conjugated to the maytansinoid DM1 via a nonreducible thioether linkage (MCC) with potential antineoplastic activity. The trastuzumab moiety of this ADC binds to HER2 on tumor cell surfaces; upon internalization, the DM1 moiety is released and binds to tubulin, thereby disrupting microtubule assembly/disassembly dynamics and inhibiting cell division and the proliferation of cancer cells that overexpress HER2. Linkage of antibody and drug through a nonreducible linker has been reported to contribute to the improved efficacy and reduced toxicity of this ADC compared to similar ADCs constructed with reducible linkers. (NCI Thesaurus)

YOU MAY ALSO LIKE

Trastuzumab

A drug used to treat breast cancer that is HER2-positive (expresses the human epidermal growth factor receptor 2). It is also used…

TRAPPC10 wt Allele

Human TRAPPC10 wild-type allele is located in the vicinity of 21q22.3 and is approximately 94 kb in length. This allele, which encodes…

TRAPPC10 Gene

This gene may play a role in protein transport.

Trapoxin

An epoxide-containing cyclotetrapeptide with antitumor activity. It is an irreversible inhibitor of histone deacetylase.

Trapezoid Bone

A carpal bone located between the trapezium and capitate bones.

Trapezoid

A four-sided polygon with only two parallel sides.